How the world made so much progress on a Covid-19 vaccine so fast
The coronavirus is an easier target for potential vaccines than other pathogens, and a prime candidate for new cutting-edge vaccine platforms.
The coronavirus is an easier target for potential vaccines than other pathogens, and a prime candidate for new cutting-edge vaccine platforms.
Cerevel Therapeutics, which AbbVie is acquiring, said Thursday its drug tavapadon, taken with the common Parkinson’s drug levodopa, showed positive results in controlling motor symptoms.
Expanding Medicaid coverage of donor breast milk would save lives. Research shows it would also save taxpayers up to $60 million a year.
For some, Microsoft’s deep involvement in setting standards for the use of AI in health care raises questions about “regulatory capture.”
As lawmakers take aim at WuXi Apptec, the issue is testing the ability of BIO’s CEO to navigate a domestic policy issue that is tangled…
A new analysis of health inequities shows that every state has deep racial and ethnic disparities in the performance of their health care systems.
Second-generation mosquito nets prevented 13 million malaria cases and 25,000 deaths in large pilot programs.
Gorevic’s departure follows a series of missed financial projections, a precipitous decline in Teladoc’s stock price, and an uninspired vision for its future.
Hospital and health insurance pricing data surfaced by new federal transparency rules are creating an opportunity for startups to help patients fight exorbitant medical bills.
The rising use of neurotechnology devices like Emotiv’s wearable EEG and Muse headbands raises a privacy question of how to protect consumers’ neural data.
Join STAT’s leading DC bureau as they take the stage with policymakers, patient advocates, and industry experts to discuss the biggest issues in health policy…